"This large cohort study represents a reassuring safety signal showing that GLP-1 drugs are not ... links between GLP-1 use and pancreatic cancer. And this just shows, as have other human studies ...

WEDNESDAY, June 11, 2025 (HealthDay News) — Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and ...

Two newer studies also supported relationships between GLP-1 receptor agonist use and reduced dementia risk ... a limitation shared by most pharmacoepidemiologic study designs, even when modern ...

SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the country -- although patients appear more ready for the shift than the ...

So the, the question we're investigating in this study is whether the use of GLP-1 receptor ... Studies show popular weight loss drugs can benefit heart disease patientsGLP-1 receptor agonists ...

5 ICON carried out a study to assess changes in payer coverage and inform current patient access to GLP-1 RA use in weight loss ... pharmacy claims for the same drugs 12 months prior to the ...

according to a study released in April by the Institute for Clinical and Economic Review. Increased use of GLP-1 drugs was not the only factor in GIC’s shortfall, but these medications have been ...

Consulting firm NECG projects that muscle-preserving GLP-1-companion drugs could ... the use of oral enobosarm in combination with semaglutide in a 168-patient randomized study.

GLP-1 agonists mimic a hormone called GLP-1, which is released from the gastrointestinal system after eating, according to study ... drug that decreases the "buzz" feeling in people with alcohol ...

The GLP-1 drug landscape ... FDA Makes a Big Shift on COVID Vaccine Policy ・Report: UnitedHealth Paid Nursing Homes to Keep Patients Out of Hospital ・'Definitely Cool' Study Digs Into Male ...